Tessera Therapeutics
Ian Lodovice currently serves as the VP of IP & Legal Affairs at Tessera Therapeutics, a position held since December 2022. Prior to this role, Ian was the Head of Legal and IP at Korro Bio, Inc. from October 2020 to December 2022. Ian's experience includes serving as Assistant General Counsel, IP Counsel at Biogen, and Principal at Fish & Richardson P.C. Additionally, Ian held the position of President at the Connecticut Intellectual Property Law Association and was a Pro Bono Committee Member for the State of Connecticut Judicial Branch. Ian’s earlier roles involved corporate counsel work at Pfizer, Inc. and associate patent attorney duties at Cantor Colburn LLP, alongside a background in research as a scientist at Pfizer Pharmaceuticals. Ian Lodovice earned a Juris Doctor degree focused on Intellectual Property from the University of Connecticut School of Law and holds a Master's degree in Molecular Genetics and a Bachelor's degree in Microbiology from the University of Rhode Island.
This person is not in any teams
This person is not in any offices
Tessera Therapeutics
3 followers
Tessera Therapeutics is an early-stage life sciences company pioneering Gene Writing, a new biotechnology designed to offer scientists and clinicians the ability to write small and large therapeutic messages into the genome, thereby curing diseases at their source. Tessera Therapeutics was founded by Flagship Pioneering, a life sciences innovation enterprise that conceives, resources, and develops first-in-category companies to transform human health and sustainability.